In Vitro Maturation of Bone Marrow-Derived Dendritic Cells via STING Activation for T Cell Priming

Area of Science:

• Immunology
• Cell Biology
• Cancer Research

Background:

• Dendritic cells (DCs) are key antigen-presenting cells bridging innate and adaptive immunity.
• The stimulator of interferon genes (STING) pathway activation by DNA promotes immune responses.
• STING pathway activation is crucial for CD8+ cytotoxic T cell activity.

Purpose of the Study:

• Establish a protocol for generating immature DCs from murine bone marrow.
• Optimize DC maturation in vitro using a STING agonist.
• Evaluate DC-primed T cell activity for cancer immunotherapy potential.

Main Methods:

• Differentiated murine bone marrow cells into immature DCs.
• Induced DC maturation using a STING agonist and tumor-derived DNA.
• Co-cultured DCs with isolated naïve T cells and assessed T cell proliferation.

Main Results:

• Optimized culture conditions significantly increased mature DC yield.
• STING-stimulated DCs induced robust CD8+ T cell proliferation.
• Demonstrated effective T cell priming by activated DCs.

Conclusions:

• Feasible in vitro generation of functional DCs was established.
• DC capacity to prime T cells via STING activation was confirmed.
• Supports DC-based platforms for novel cancer immunotherapies.